CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company's lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta-thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. It also develops CTX110, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting cluster of differentiation 19 positive malignancies; CTX120, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting B-cell maturation antigen for the treatment of relapsed or refractory multiple myeloma; and CTX130, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting Cluster of Differentiation 70 to treat various solid tumors and hematologic malignancies. In addition, the company develops VCTX210, a gene-edited immune-evasive stem cell-derived product candidate for the treatment of treatment of type 1 diabetes; and pursues various in vivo gene-editing programs that target the liver, lung, muscle, and central nervous system diseases. It has strategic partnerships with Bayer Healthcare LLC, Vertex Pharmaceuticals Incorporated, ViaCyte, Inc., Nkarta, Inc., and Capsida Biotherapeutics. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of CRISPR Therapeutics AG.
CRISPR Therapeutics AG business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of CRISPR Therapeutics AG are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of CRISPR Therapeutics AG , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of CRISPR Therapeutics AG including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of CRISPR Therapeutics AG and all latest updates of the company are provided.
The 2025 version of CRISPR Therapeutics AG report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 CRISPR Therapeutics AG- Key Facts
2.2 CRISPR Therapeutics AG- Geographic Locations
2.3 CRISPR Therapeutics AG- Subsidiaries and Affiliates
2.4 CRISPR Therapeutics AG- Business Divisions
2.5 CRISPR Therapeutics AG- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. CRISPR Therapeutics AG Strategic Analysis Review
3.1 CRISPR Therapeutics AG- Key Strategies
3.2 CRISPR Therapeutics AG- Company Outlook Statement
3.3 CRISPR Therapeutics AG- SWOT Analysis
3.3.1 CRISPR Therapeutics AG- Key Strengths
3.3.2 CRISPR Therapeutics AG- Key Weaknesses
3.3.3 CRISPR Therapeutics AG- Potential Opportunities
3.3.4 CRISPR Therapeutics AG- Potential Threats
3.4 CRISPR Therapeutics AG- Key Competitors
4. Business Description of the Company
4.1 CRISPR Therapeutics AG- Business Overview
4.2 CRISPR Therapeutics AG- Operations by Segment
5 Products and Services Details
5.1 CRISPR Therapeutics AG- Key Products
5.2 CRISPR Therapeutics AG- Key Service Areas
5.3 CRISPR Therapeutics AG- Key Brands
6 Company Developments
6.1 CRISPR Therapeutics AG- Company History
6.2 CRISPR Therapeutics AG- Latest Developments
7 Financial Analysis
7.1 CRISPR Therapeutics AG- Income Statements
7.2 CRISPR Therapeutics AG- Balance Sheet
7.3 CRISPR Therapeutics AG- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 CRISPR Therapeutics AG- Direct Competitors
8.2 CRISPR Therapeutics AG- Competitor Financial Ratios comparison
8.3 CRISPR Therapeutics AG- Competitor Stock Charts Comparison
8.4 CRISPR Therapeutics AG- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
